Aleniglipron, an experimental GLP-1 treatment in the form of a pill, helped adults with obesity or overweight lose up to 12.1% of their body weight over 36 weeks. The corresponding study was published ...

Worldwide and in the United States, lung cancer is the leading cause of cancer and cancer death, and in the US, about 15% of lung cancer cases arise in people who have never smoked. Long term exposure ...

A Neanderthal gene associated with bone and muscle growth still exists in some people, who tend to have more muscle mass and other Neanderthal-like features, according to a new study in Current ...

Understanding RNA diversity requires more than measuring gene expression—it also depends on accurately identifying the transcript isoforms that drive cellular function. This application note explores ...

Dronabinol, a prescription form of psychoactive cannabinoid THC, reduced the frequency and intensity of PTSD-related nightmares. The corresponding study was published in Nature Medicine. Up to 71% of ...

PFAS is no longer a niche contaminant conversation. It's a federal regulatory priority with enforceable deadlines, and that shift is rewriting procurement plans across environmental, chemistry, and ...

Hyper and Hypoparathyroid diseases are often latent conditions with significant morbidity and at times mortality. The symptoms range from the obvious, such as kidney stones, bone fractures, and ...

Advances in multi-scale spatial proteomics and computational analysis are enabling deeper exploration of tissue biology across cancer and neurological applications. This presentation will highlight a ...

The programme of this webinar will cover the clinical value and practical application of point-of-care testing in the ...

Join us for an interactive webinar focused on the practical analysis of Next Generation Flow™ measurable residual disease (MRD) in Multiple Myeloma through a real case example. We will navigate ...

Infectious mononucleosis has been recognized as a unique disease for more than 100 years and its cause, Epstein-Barr virus (EBV), was discovered more than 50 years ago. Yet, there is no licensed ...

Regulatory guidance defines the framework—but it doesn't make critical decisions. For drug developers preparing IND or CTA submissions, the white space gap between guidance and execution, along with ...